{
  "id": "PD_TACHYCARDIA_ADDITIVE",
  "name": "Additive tachycardia risk with multiple HR-increasing drugs",
  "domain": "PD",
  "severity": "caution",
  "rule_class": "adjust_monitor",
  "actions": [
    "Monitor heart rate and symptoms (palpitations, chest pain, dizziness).",
    "Assess for arrhythmia history and other sympathomimetics.",
    "Consider dose reduction or alternative therapy if symptomatic."
  ],
  "logic": {
    "pd_overlap": { "effect_id": "tachycardia", "min_magnitude": "high" },
    "rationale": [
      "Both drugs can increase heart rate.",
      "Combined effects increase risk of symptomatic tachycardia."
    ]
  },
  "explanation_template": "{A_name} and {B_name} can both increase heart rate. Using them together may increase tachycardia risk, especially in patients with arrhythmia history or other stimulants.",
  "references": [
    { "source": "Educational note", "citation": "PD stacking: shared tachycardia domain implies additive HR elevation." }
  ]
}